Rapid drug development and patented advanced pharmaceutical manufacturing company providing essential medicines through scalable domestic API production. Making medicine faster, greener, safer in the U.S. Bright Path Laboratories (BPL) is positioned to immediately fill gaps in the drug supply chain in response to the COVID-19 pandemic and other medicine shortages. We have the infrastructure and technical capacity for the agile research and development of advanced pharmaceutical manufacturing that is scalable, that helps us train a future workforce for research and is able to support Federal agencies to rapidly address drug shortages. Americans should never be dependent on another country for life-saving medicines or key ingredients to make them.